ArticleCancer2011

Complications associated with erythropoietin-stimulating agents in patients with metastatic breast cancer: a Surveillance, Epidemiology, and End Results-Medicare study.

Mariana Chavez-MacGregor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.